Diabetes 52 , 726733 (2003)
Lyttle MH, Satyam A, Hocker MD, Bauer KE, Caldwell CG, Hui HC, Morgan AS, Mergia A, Kauvar LM (1994) Glutathione-S-transferase activates novel alkylating agents
Abbreviations ASCVD: Atherosclerotic cardiovascular disease ATE: Average treatment effect BMI: Body mass index CI: Confidence interval CKD: Chronic kidney disease CV: Cardiovascular eGFR: Estimated glomerular filtration rate GIP: Glucose-dependent insulinotropic polypeptide GLP-1RA: Glucagonlike peptide-1 receptor agonist HBA 1c : Glycated hemoglobin HR: Hazard ratio ICD-10-CM: International Classification of Diseases, Tenth Revision, Clinical Modification MACE: Major adverse cardiovascular event MI: Myocardial infarction OW: Once weekly PY: Person-years RCTs: Randomized controlled trials SGLT2i: Sodium-glucose cotransporter 2 inhibitor SMDs: Standardized mean differences T2D: Type 2 diabetes References Fonseca VA
Frequently Asked Questions How quickly will I notice appetite changes on GLP-1 medication
It can be misconstrued, Medina said